| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/08/2008 | EP1976498A2 Chemical compounds |
| 10/08/2008 | EP1976497A2 Treatment of viral infections |
| 10/08/2008 | EP1976496A1 Overall therapeutic approach in the treatment of neurodegenerative diseases |
| 10/08/2008 | EP1976495A2 Compounds acting on the serotonin transporter |
| 10/08/2008 | EP1976494A1 Adenosine a3 receptor agonists for the treatment of dry eye disorders |
| 10/08/2008 | EP1976492A2 Drug delivery systems comprising weakly basic drugs and organic acids |
| 10/08/2008 | EP1976491A2 Drug delivery systems comprising weakly basic selective serotonin 5-ht3 blocking agent and organic acids |
| 10/08/2008 | EP1976490A1 Zaltoprofen-containing sustained release tablet and process for the preparation thereof |
| 10/08/2008 | EP1976489A1 Multiple unit type sustained release oral formulation and process for the preparation thereof |
| 10/08/2008 | EP1976487A2 Sustained release dosage form of phenothiazine derivatives containing channelizer |
| 10/08/2008 | EP1976470A2 Laser energy calibration based on optical measurement |
| 10/08/2008 | EP1976396A2 Composition comprising polyunsaturated fatty acids for improving membrane composition |
| 10/08/2008 | EP1976395A2 Composition comprising polyunsaturated fatty acids for improving membrane composition |
| 10/08/2008 | EP1976381A2 Tri-substituted 2-benzhydryl-5-benzlamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3,6-disubstituted pyran derivatives |
| 10/08/2008 | EP1976378A2 Compounds for the treatment of metabolic disorders |
| 10/08/2008 | EP1976377A2 Compounds for the treatment of metabolic disorders |
| 10/08/2008 | EP1922135A4 Hindered cyclic polyamines and their salts for acid gas scrubbing process |
| 10/08/2008 | EP1881830B1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives the treatment of infertility |
| 10/08/2008 | EP1824863B1 Silicon compounds and their use |
| 10/08/2008 | EP1790357B1 Perorally administrable antimicrobial composition |
| 10/08/2008 | EP1786436A4 Method for improving ventilatory efficiency |
| 10/08/2008 | EP1781596B1 Amino acid derived prodrugs of propofol compositions and uses thereof |
| 10/08/2008 | EP1778680B1 Spirocyclic cyclohexane derivatives |
| 10/08/2008 | EP1778208A4 Extended-release capsules comprising venlafaxine hydrochloride |
| 10/08/2008 | EP1751553B1 Identification of anti-prion drugs by high-throughput screening based on sift |
| 10/08/2008 | EP1734940B1 Combinations of deramciclane and opioids for use as analgesics |
| 10/08/2008 | EP1732567B1 Use of a phenothiazine derivative for preventing and/or treating hearing loss |
| 10/08/2008 | EP1725546B1 Pyrazolyl indolyl derivatives as ppar activators |
| 10/08/2008 | EP1715859B1 Method of treating and diagnosing sleep disordered breathing using zonisamide and means for carrying out the method |
| 10/08/2008 | EP1703901B1 Pharmaceutical composition comprising 2,4-dichlorobenzyl alcohol and amylmetacresol |
| 10/08/2008 | EP1689411B1 Graduated estrogen contraceptive |
| 10/08/2008 | EP1678185B1 2,3-dihydro-6-nitroimidazo [2,1-b] oxazole compounds for the treatment of tuberculosis |
| 10/08/2008 | EP1675586A4 Methods for treating non-microbial inflammatory skin conditions |
| 10/08/2008 | EP1660493B1 Peptidyl heterocyclic ketone derivatives and preparation processes |
| 10/08/2008 | EP1646390B1 A1 adenosine receptor antagonists |
| 10/08/2008 | EP1641799B8 Imidazo-pyridazinone derivatives and imidazo-pyridone derivatives, production thereof, and use thereof as medicaments |
| 10/08/2008 | EP1635875B1 In-situ gelling drug delivery system |
| 10/08/2008 | EP1633348B1 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B sb 1 /sb RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES |
| 10/08/2008 | EP1606283B1 P38 inhibitors and methods of use thereof |
| 10/08/2008 | EP1601359B1 Liquid pharmaceutical formulations of palonosetron |
| 10/08/2008 | EP1597234B1 Novel compounds |
| 10/08/2008 | EP1583522B1 Use of cyclin d1 inhibitors for breast cancer treatment |
| 10/08/2008 | EP1572694B1 Pyrrolo[2,1-c][1,4] benzodiazepines as vasopressin agonists |
| 10/08/2008 | EP1569931B1 Heterocyclic compounds as ccr5 antagonists |
| 10/08/2008 | EP1540338B1 Bioequivalence test for iron-containing formulations |
| 10/08/2008 | EP1539693B9 Cannabinoid receptor agonists |
| 10/08/2008 | EP1523469B1 Cinnamide derivatives |
| 10/08/2008 | EP1511466B1 Use of glycosaminoglycans such as e.g. heparin for the treatment of respiratory disorders such as copd |
| 10/08/2008 | EP1503732B1 Reduced formate poly(alkylene oxides) with reboxetine for reducing impurity formation |
| 10/08/2008 | EP1499360B1 Formulation comprising buprenorphine |
| 10/08/2008 | EP1492527B1 Process for preparing a finely self-emulsifiable pharmaceutical composition |
| 10/08/2008 | EP1487469B1 Co-beadlet of dha and rosemary |
| 10/08/2008 | EP1485390B1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors |
| 10/08/2008 | EP1485363B1 Cyclic amides |
| 10/08/2008 | EP1476128B1 Lipase inhibiting composition |
| 10/08/2008 | EP1469000B1 Novel crystalline tricyclic triazolobenzazepine derivative |
| 10/08/2008 | EP1465521A4 System and method for the pretreatment of the endplates of an intervertebral disc |
| 10/08/2008 | EP1464331B1 Compressed oral pharmaceutical dosage form, with an enteric coating, which contains an acid-labile benzimidazole compound |
| 10/08/2008 | EP1455761B1 Pharmaceutical compositions for the oral administration of heparin or derivatives thereof |
| 10/08/2008 | EP1419144B1 Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues |
| 10/08/2008 | EP1392323B1 Use of a vitamin d3 analogue for the treatment of autoimmune diabetes |
| 10/08/2008 | EP1389100B1 Novel methods for the treatment and prevention of pain using stress-activated protein kinase inhibitors |
| 10/08/2008 | EP1379246B1 Nociceptin analogs |
| 10/08/2008 | EP1370298B1 Elongated and multiple spacers in activatible prodrugs |
| 10/08/2008 | EP1357811B1 Composition and method for smoke detoxification |
| 10/08/2008 | EP1344528B1 External skin preparations and process for producing the same |
| 10/08/2008 | EP1337264B1 A nutritional dietary system, formulation, kit and method for use in preparing an individual for a predetermined activity |
| 10/08/2008 | EP1335902B1 Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 10/08/2008 | EP1333818B1 Titratable dosage transdermal delivery system |
| 10/08/2008 | EP1296633B1 Medicinal product package for eradication therapy |
| 10/08/2008 | EP1295881B1 Compositions for treating or preventing malaria and method of treating malaria |
| 10/08/2008 | EP1283042B1 Aqueous liquid preparation of pranoprofen |
| 10/08/2008 | EP1274398B1 Methods for thepreparation of effervescent granules |
| 10/08/2008 | EP1253918B1 Compositions comprising modafinil for the treatment of attention deficit hyperactivity disorder |
| 10/08/2008 | EP1189626B1 Composition for preventing tumoral growth |
| 10/08/2008 | EP1163364B1 Screening method involving mgdg synthase |
| 10/08/2008 | EP1064298B1 Inhibitors of caspases |
| 10/08/2008 | EP1043995B9 INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS |
| 10/08/2008 | EP1032667B1 Platelet specific antigens and their pharmacological uses |
| 10/08/2008 | EP0902664B1 Synchronising of animal oestrus and intra vaginal devices useful therein |
| 10/08/2008 | EP0752005B1 Compacted nucleic acids and their delivery to cells |
| 10/08/2008 | CN101283279A Screening and therapeutic method for nsclc targeting CDCA1-KNTC2 complex |
| 10/08/2008 | CN101282987A Glucocorticoid 16alpha,17alpha-isoxazolidines as anti-inflammatory agents |
| 10/08/2008 | CN101282984A Immunogens for meningitidis-a vaccines |
| 10/08/2008 | CN101282981A Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections |
| 10/08/2008 | CN101282978A Macrocylic inhibitors of hepatitis c virus |
| 10/08/2008 | CN101282977A Xanthine derivatives as selective hm74a agonists |
| 10/08/2008 | CN101282976A Xanthine derivatives as selective HM74A agonists |
| 10/08/2008 | CN101282975A Compounds and compositions as protein kinase inhibitors |
| 10/08/2008 | CN101282974A Benzimidazole derivatives as SIRTUIN modulators |
| 10/08/2008 | CN101282973A Imidazopyridine derivatives as cannabinoid receptor ligands |
| 10/08/2008 | CN101282968A Novel polymorphous form and the amorphous form of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide |
| 10/08/2008 | CN101282966A Heteroarylcarbamoylbenzene derivatives for the treatment of diabetes |
| 10/08/2008 | CN101282964A Oxopyridyl quinoline amides as NK3 receptor modulators |
| 10/08/2008 | CN101282963A Pyrazole derivatives as therapeutic agents |
| 10/08/2008 | CN101282962A Compounds for the treatment of inflammatory disorders |
| 10/08/2008 | CN101282961A Alkylpyridyl quinolines as NK3 receptor modulators |
| 10/08/2008 | CN101282960A RAF inhibitor compounds and methods |
| 10/08/2008 | CN101282957A 新的药物化合物 New pharmaceutical compounds |
| 10/08/2008 | CN101282955A Crystalline forms of docetaxel and processes for their preparation |